CS-10BR05

N/A

Report date: 2025/02/08 11:46:41

Base Information

Drug NameCS-10BR05

Drug Alias NameBone marrow-derived mesenchymal stem cells自体骨髓间充质干细胞疗法（Corestem）Autologous bone marrow-derived mesenchymal stem cells (Corestem)CS-10BR05

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsMultiple System Atrophy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCorestem Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCorestemchemon Inc

Active IndicationsN/A

Inactive IndicationsMultiple System Atrophy

Other Information

ATC CodeN/A